DTIL

PRECISION BIOSCIENCES INC

DTIL
NasdaqSmall CapHealthcare

13F Pro Quality Score

10.6/100

Rank #2,909 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

1.5/100

Profitability

7.3/100

Balance Sheet

5.2/100

Earnings Quality

7.8/100

Free Cash Flow

6.1/100

Institutional Flow

18.4/100

Revenue Scale

7.9/100

Dilution Risk

6.4/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$0

Net Income

Q2 2026
EDGAR

$-32.65M

EPS (Diluted)

Q2 2026
EDGAR

$-1.26

Free Cash Flow

Q2 2026
EDGAR

$-13.44M

Top Institutional Holders

as of Q2 2026
$139.25M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…